We are live on
!
Find out more
ARTA
A.R.T. Advisors Portfolio holdings
AUM
$1.79M
1-Year Est. Return
57.47%
This Fund
S&P 500
This Quarter
Est. Return
+1.41%
1 Year Est. Return
+57.47%
3 Year Est. Return
+81.79%
5 Year Est. Return
+178.88%
10 Year Est. Return
–
AUM
$2B
AUM Growth
-$231M
(-10%)
Cap. Flow
-$214M
Cap. Flow
% of AUM
-10.69%
Top 10 Holdings %
Top 10 Hldgs %
6.82%
Holding
1,904
New
580
Increased
368
Reduced
360
Closed
591
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$13.5M |
| 2 |
Amgen
AMGN
|
+$13.4M |
| 3 |
Charter Communications
CHTR
|
+$12M |
| 4 |
Amazon
AMZN
|
+$11M |
| 5 |
CELG
Celgene Corp
CELG
|
+$10.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$20M |
| 2 |
LNKD
LinkedIn Corporation
LNKD
|
+$19.3M |
| 3 |
Pfizer
PFE
|
+$19.2M |
| 4 |
Alkermes
ALKS
|
+$14.8M |
| 5 |
Visa
V
|
+$12.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 14.12% |
| 2 | Healthcare | 11.46% |
| 3 | Technology | 11.32% |
| 4 | Industrials | 11.2% |
| 5 | Materials | 8.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ESPR
1051
DELISTED
Esperion Therapeutics
ESPR
| $233K | 0.01% |
23,650
-177,208
| -88% | -$2.94M |
|
|
MITL
1052
DELISTED
Mitel Networks Corporation
MITL
| $233K | 0.01% |
+37,184
| New | +$254K |
|
|
ENH
1053
DELISTED
Endurance Specialty Holdings Ltd
ENH
| $232K | 0.01% |
3,468
-9,700
| -74% | -$636K |
|
1054
LeMaitre Vascular
LMAT
$2.34B
| $231K | 0.01% |
16,233
-2,800
| -15% | -$42.8K |
|
|
VIVS
1055
VivoSim Labs
VIVS
$1.32M
| $231K | 0.01% |
+259
| New | +$174K |
|
|
WG
1056
DELISTED
Willbros Group
WG
| $229K | 0.01% |
90,816
+50,400
| +125% | +$139K |
|
1057
Hudbay
HBM
$9.71B
| $227K | 0.01% |
47,653
+35,300
| +286% | +$148K |
|
|
HAPN
1058
Happen Inc
HAPN
$2.21B
| $227K | 0.01% |
+10,600
| New | +$305K |
|
1059
Varonis Systems
VRNS
$5.3B
| $227K | 0.01% |
28,473
-34,200
| -55% | -$251K |
|
|
NATI
1060
DELISTED
National Instruments Corp
NATI
| $227K | 0.01% |
+8,289
| New | +$231K |
|
1061
Albany International
AIN
$2.17B
| $226K | 0.01% |
5,670
-18,900
| -77% | -$746K |
|
|
MASI
1062
DELISTED
Masimo
MASI
| $226K | 0.01% |
+4,316
| New | +$203K |
|
1063
SunCoke Energy
SXC
$782M
| $226K | 0.01% |
+38,926
| New | +$246K |
|
|
FRSH
1064
DELISTED
Papa Murphy's Holdings, Inc
FRSH
| $226K | 0.01% |
+34,087
| New | +$315K |
|
|
TUP
1065
DELISTED
Tupperware Brands Corporation
TUP
| $225K | 0.01% |
4,010
-4,900
| -55% | -$280K |
|
1066
Glacier Bancorp
GBCI
$6.4B
| $224K | 0.01% |
8,437
-7,600
| -47% | -$198K |
|
|
MDC
1067
DELISTED
M.D.C. Holdings, Inc.
MDC
| $224K | 0.01% |
12,813
-104,996
| -89% | -$1.82M |
|
|
XENT
1068
DELISTED
Intersect ENT, Inc
XENT
| $224K | 0.01% |
17,372
-7,800
| -31% | -$122K |
|
|
SHLM
1069
DELISTED
Schulman (A.) Inc
SHLM
| $223K | 0.01% |
+9,152
| New | +$234K |
|
|
SNC
1070
DELISTED
State National Companies, Inc.
SNC
| $223K | 0.01% |
+21,244
| New | +$238K |
|
1071
Harmony Gold Mining
HMY
$9.8B
| $222K | 0.01% |
+61,756
| New | +$214K |
|
1072
Itron
ITRI
$4.51B
| $222K | 0.01% |
+5,166
| New | +$218K |
|
1073
McGrath RentCorp
MGRC
$2.92B
| $222K | 0.01% |
7,276
-3,400
| -32% | -$91.7K |
|
1074
Regenxbio
RGNX
$606M
| $220K | 0.01% |
+27,600
| New | +$306K |
|
|
ZVO
1075
DELISTED
Zovio Inc. Common Stock
ZVO
| $219K | 0.01% |
+30,357
| New | +$260K |
|
Similar funds
MA
FFIM
LC
YEPV
AAM
CCM
IR
IFC
A.R.T. Advisors's Q2 2016 Portfolio in Review
As of Q2 2016, A.R.T. Advisors held 1,904 positions worth $2B, down 10% from $2.24B the previous quarter. Its ten largest holdings account for 6.8% of the portfolio.
A.R.T. Advisors withdrew a net $214M in Q2 2016, closing 591 positions and reducing 360 holdings. Its most notable exit was Johnson & Johnson, an estimated $20M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Technology.
Against the trend, A.R.T. Advisors opened a new position in Mastercard worth $12.4M.
- A.R.T. Advisors's largest Q2 2016 buy was Mastercard: 141,390 shares worth $12.4M.
- A.R.T. Advisors added most to Paramount Global Class B in Q2 2016, an estimated $8.3M increase.
- A.R.T. Advisors's biggest Q2 2016 reduction was Visa, cutting an estimated $12.8M.
- A.R.T. Advisors fully exited Johnson & Johnson in Q2 2016, selling an estimated $20M.
- A.R.T. Advisors's ten largest holdings make up 6.8% of its $2B portfolio in Q2 2016.
- A.R.T. Advisors opened 580 new positions and closed 591 in Q2 2016.
- A.R.T. Advisors's portfolio value fell 10% quarter-over-quarter to $2B.
Based on A.R.T. Advisors's 13F filing for Q2 2016, filed 15 Aug 2016.